Make an enquiry
Refer a patient
Pay my bill
0808 304 2332

We noticed you are on our UK page. Want to switch regions? Choose from the options:

AU
ES
GenesisCare - logo
Patients
Find a centre
Find a doctor
0808 304 2332
Make an enquiry
Refer a patient
Pay my bill

We noticed you are on our UK page. Want to switch regions? Choose from the options:

AU
ES
Find a centre
Find a doctor
0808 304 2332
2025-08-01T00:00:00.000+01:00

Telios Study

Telios Study
Blood cancer

Trial overview

Disease

Myelofibrosis

Sponsor

Telios Pharma

Description

Telios Pharma A Phase 2 Multicenter Study of TL-895 in Subjects with Myelofibrosis, Indolent Systemic Mastocytosis, Monoclonal Mast Cell Activation Syndrome, or Non-Monoclonal Mast Cell Activation Syndrome clinical trial

Study details

For detailed information on this trial, please click here

Trial status

Oxford now open

Location

Oxford

Windsor

Oxford Windsor :::

Principal Investigator

Dr Adam Mead

MBBS, MD, FRCP, FRCPath

Consultant Haematologist

View more